All
All
Parallel
Title
Appellant
Respondent
Lawyer
Parallel Search is an AI-driven legal research functionality that uses natural language understanding to find conceptually relevant case law, even without exact keyword matches.
Hi, I'm AMICUS. Your GPT powered virtual legal assistant.
Let's chat.
Log in
Sign Up
Select Country
India
UK
&
Ireland
AMICUS AI
CaseIQ
Keyword Research
Parallel Search
Browse
Commentaries
Columns
My Project
New chat
Federal
U.S. Supreme Court
Federal Circuit
1st Circuit
2d Circuit
3d Circuit
4th Circuit
5th Circuit
6th Circuit
7th Circuit
8th Circuit
9th Circuit
10th Circuit
11th Circuit
Court of Appeals for the D.C. Circuit
Board of Immigration Appeals
Special Courts
Bankruptcy
State
Alabama
Alaska
Arkansas
Arizona
California
Colorado
Connecticut
Delaware
District Of Columbia
Florida
Georgia
Guam
Hawaii
Iowa
Idaho
Illinois
Indiana
Kansas
Kentucky
Louisiana
Massachusetts
Maryland
Maine
Michigan
Minnesota
Missouri
Mississippi
Montana
Nebraska
North Carolina
North Dakota
New Hampshire
New Jersey
Northern Mariana Islands
New Mexico
Nevada
New York
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Virginia
Vermont
Washington
Wisconsin
West Virginia
Wyoming
21 C.F.R. § 878.4430 : Food and Drugs — FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES — MEDICAL DEVICES — GENERAL AND PLASTIC SURGERY DEVICES — SURGICAL DEVICES — Microneedling device for aesthetic use
Text
(a)
Identification.
A microneedling device for aesthetic use is a device using one or more needles to mechanically puncture and injure skin tissue for aesthetic use. This classification does not include devices intended for transdermal delivery of topical products such as cosmetics, drugs, or biologics.
(b)
Classification.
Class II (special controls). The special controls for this device are:
(1)
The technical specifications and needle characteristics must be identified, including needle length, geometry, maximum penetration depth, and puncture rate.
(2)
Non-clinical performance data must demonstrate that the device performs as intended under anticipated conditions of use. The following performance characteristics must be tested:
(i)
Accuracy of needle penetration depth and puncture rate;
(ii)
Safety features built into the device to protect against cross-contamination, including fluid ingress protection; and
(iii)
Identification of the maximum safe needle penetration depth for the device for the labeled indications for use.
(3)
Performance data must demonstrate the sterility of the patient-contacting components of the device.
(4)
Performance data must support the shelf life of the device by demonstrating continued sterility, package integrity, and device functionality over the intended shelf life.
(5)
Performance data must demonstrate the electrical safety and electromagnetic compatibility (EMC) of all electrical components of the device.
(6)
Software verification, validation, and hazard analysis must be performed for all software components of the device.
(7)
The patient-contacting components of the device must be demonstrated to be biocompatible.
(8)
Performance data must validate the cleaning and disinfection instructions for reusable components of the device.
(9)
Labeling must include the following:
(i)
Information on how to operate the device and its components and the typical course of treatment;
(ii)
A summary of the device technical parameters, including needle length, needle geometry, maximum penetration depth, and puncture rate;
(iii)
Validated methods and instructions for reprocessing of any reusable components;
(iv)
Disposal instructions; and
(v)
A shelf life.
(10)
Patient labeling must be provided and must include:
(i)
Information on how the device operates and the typical course of treatment;
(ii)
The probable risks and benefits associated with use of the device; and
(iii)
Postoperative care instructions.
21 C.F.R. §878.4430
83 FR 26577, 6/8/2018
×